SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (13279)8/13/1998 10:57:00 PM
From: VLAD  Read Replies (1) of 23519
 
Kahuna,

If these reps have already detailed all the urologists back in 1997 what more can they really say to them other than answer any questions they may have. I doubt there is a urologist out there who doesn't already know all about MUSE.

The ones who need the detailing are the PCPs. As Wilson said in the last cc, Viagra has totally changed the way ED will now be treated ie the PCP not the urologist will be the first person sought for the problem. Vivus needs the domestic partner who has a large sales force that can hit most of the PCPs in a months time. Once a PCP knows how to properly titrate and use the product domestic sales will recover. I think that it will be very interesting to see exactly how quickly the script numbers will increase if and when a partner takes over.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News